Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 17, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 19, 2026
OfficerIndirect holdingOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001673232-26-000010
Filed / recorded
Feb 19, 2026, 2:31 AM UTC
Added to OQRO
Oct 6, 2026, 9:34 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
UNITED THERAPEUTICS Corp
Issuer CIK
1082554
Ticker
UTHR
Reporting person
Michael Benkowitz
Relationship
Officer
Officer title
PRESIDENT AND COO
Security
Common Stock
Table
Derivative (Table II)
Transaction date
Feb 17, 2026
Transaction code
M
Shares / units
14,625
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
9,375
Ownership form
Indirect — by Trust
Amendment
No
Footnotes from the filing
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025.
Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power.